Intelligence

Top Specialty Pharmacy Costs

I am exploring ways to manage the costs of treating cancer, RA and hepatitis C. When presented with high drug costs for these three conditions, how are insurers and PBMs managing the costs of treating members — prior authorization, step therapy, rebates, choosing more efficient treatment settings, narrow networks, promoting medication adherence, MTM, personalized medicine initiatives through gene testing. I’m looking to speak with PBMs, insurers, consultants and pharmacists.